Sort
34,240 grants matching “atherosclerosis”
Primary Prevention to Reduce Cardiovascular Morbidity and Optimize Cancer Outcomes
$674,452Aniket A Kawatkar · Kaiser Foundation Research Institute · R01 · FY2024 · HL
Role of Complement Activation in Severe COVID-19
$674,370Xuebin Qin · Tulane University Of Louisiana · R01 · FY2025 · HL
Role of Complement Activation in Severe COVID-19
$674,314Xuebin Qin · Tulane University Of Louisiana · R01 · FY2023 · HL
SGLT2 Inhibitors, Ketogenesis, and Ketoacidosis
$674,244Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2023 · DK
SGLT2 Inhibitors, Ketogenesis, and Ketoacidosis
$674,244Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2025 · DK
Discovery, Replication, and Validation of Biomarkers of the DASH Diet and Hypertension
$674,049Casey Marie Rebholz · Johns Hopkins University · R01 · FY2024 · HL
Human Coronary Artery Plaque Transcriptomes and Cardiovascular Risk Assessment
$673,960Michael E Widlansky · Medical College Of Wisconsin · R01 · FY2025 · HL
Comprehensive Magnetic Resonance in PAD
$673,798Christopher M Kramer · University Of Virginia · R01 · FY2009 · HL
Biomarkers for Complications in Type 1 Diabetes (DCCT/EDIC)
$673,794Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2010 · DK
Managing Atherosclerosis by Modulating HDL Function
$673,750M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2016 · HL
Metal Exposure and Early Cardiovascular Risk in Adult E-Cigarette Users
$673,735Ana Navas-Acien · Columbia University Health Sciences · R01 · FY2020 · ES
Cardioprotective Role of Humanin
$673,693Radhika Hiren Muzumdar · University Of Pittsburgh At Pittsburgh · R56 · FY2018 · HL
PET Tracer for Imaging of Lung Inflammation
$673,682Vijay Sharma · Washington University · R01 · FY2024 · HL
The Anti-angiogenic VEGF165b and VEGFR1 Signaling in Peripheral Artery Disease
$673,667Brian H Annex · Augusta University · R01 · FY2022 · HL
The Anti-angiogenic VEGF165b and VEGFR1 Signaling in Peripheral Artery Disease
$673,667Brian H Annex · Augusta University · R01 · FY2021 · HL
Variant Determinants of African American Limb Pathology in Peripheral Arterial Disease
$673,663Joseph Matthew McClung · East Carolina University · R01 · FY2021 · HL
Epigenetic Reprogramming in Atherosclerosis
$673,647Eicke Latz · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · HL
Epigenetic Reprogramming in Atherosclerosis
$673,647Eicke Latz · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · HL
Epigenetic Reprogramming in Atherosclerosis
$673,647Eicke Latz · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · HL
Inflammatory Genomics in Human Carotid Artery Disease
$673,643University Of Washington · R01 · FY2003 · HL
Gut microbiota and metabolite interactions in atherosclerosis
$673,600Aldons Jake Lusis · University Of California Los Angeles · R01 · FY2019 · HL
Stroke and aPL: Community-Based Clinicopathological Study
$673,564Steven R Levine · Suny Downstate Medical Center · R01 · FY2011 · HL
Theranostic Approach to Asthma Using Anti-Angiogenic Nanomedicine
$673,514Gregory M Lanza · Washington University · R01 · FY2016 · HL
Postdoctoral Training in Arteriosclerosis Research
$673,488Henry N Ginsberg · Columbia University Health Sciences · T32 · FY2024 · HL
Adenylyl Cyclase Type 5 Inhibition to Treat Myocardial Infarction
$673,385Dorothy E Vatner · Vasade Biosciences, Inc. · R44 · FY2019 · HL